4.7 Article

Hippo Reprograms the Transcriptional Response to Ras Signaling

Journal

DEVELOPMENTAL CELL
Volume 42, Issue 6, Pages 667-+

Publisher

CELL PRESS
DOI: 10.1016/j.devcel.2017.08.013

Keywords

-

Funding

  1. Swiss National Science Foundation [PP00P3_150682]
  2. Flanders Research Foundation (FWO)
  3. FWO [G.0954.16, G.0306.16, G.0640.13, G.0791.14, G.0C04.17]
  4. Special Research Fund (BOF) KU Leuven [PF/10/016, OT/13/103]
  5. Foundation Against Cancer grant [2012-F2]
  6. ERC CoG [724226_cis-CONTROL]
  7. Stowers Institute for Medical Research
  8. NIH New Innovator Award [1DP2 OD004561-01]
  9. Flemish Agency for Innovation by Science and Technology
  10. Swiss National Science Foundation (SNF) [PP00P3_150682] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

Hyperactivating mutations in Ras signaling are hallmarks of carcinomas. Ras signaling mediates cell fate decisions as well as proliferation during development. It is not known what dictates whether Ras signaling drives differentiation versus proliferation. Here we show that the Hippo pathway is critical for this decision. Loss of Hippo switches Ras activation from promoting cellular differentiation to aggressive cellular proliferation. Transcriptome analysis combined with genetic tests show that this excessive proliferation depends on the synergistic induction of Ras target genes. Using ChIPnexus, we find that Hippo signaling keeps Ras targets in check by directly regulating the expression of two key downstream transcription factors of Ras signaling: the ETS-domain transcription factor Pointed and the repressor Capicua. Our results highlight how independent signaling pathways can impinge on each other at the level of transcription factors, thereby providing a safety mechanism to keep proliferation in check under normal developmental conditions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available